ACE Inhibitors and ARBs
Cross-source consensus on ACE Inhibitors and ARBs from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Benefits
Comparisons
Highlighted claims
- ACE inhibitors and ARBs showed no association with reduced stroke recurrence in non-AF patients. — Effectiveness of antihypertensive drugs for secondary prevention of ischaemic stroke: a nationwide historic cohort study
- ACE inhibitors and ARBs showed MACE or mortality benefit despite lacking stroke-specific benefit in the cohort. — Effectiveness of antihypertensive drugs for secondary prevention of ischaemic stroke: a nationwide historic cohort study
- The study does not confirm ACE inhibitor effectiveness for stroke recurrence shown in prior trial contexts. — Effectiveness of antihypertensive drugs for secondary prevention of ischaemic stroke: a nationwide historic cohort study
- The absence of stroke-specific benefit from ACEi or ARB may be due to concurrent secondary-prevention therapies, polypharmacy, or unmeasured hypotension. — Effectiveness of antihypertensive drugs for secondary prevention of ischaemic stroke: a nationwide historic cohort study